SCHEMBL984836

SCHEMBL984836

OCC(O)CO[Si](OCC(O)CO)(OCC(O)CO)OCC(O)CO

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
ALDH1A1 P00352 1/20 0.44
USP2 O75604 1/20 0.37
THRB P10828 1/20 0.36
CYP1A2 P05177 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 1/20 0.33
ATM Q13315 1/20 0.33
AGTR1 P30556 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DUSP3 P51452 1/20 0.32
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31
CSNK2A1 P68400 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8386335 0.88 USP2 (0.39) LMNAALDH1A1USP2CYP1A2KDM4E
SCHEMBL10818291 0.85 LMNA (0.37) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL226863 0.80 LMNA (0.42) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL13416103 0.79 LMNA (0.34) LMNAALDH1A1USP2CYP1A2KDM4E
SCHEMBL6240929 0.78 LMNA (0.40) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL30443539 0.76 LMNA (0.38) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL14719495 0.74 TSHR (0.35) KDM4ETSHRCSNK2A1
SCHEMBL4641295 0.72 LMNA (0.40) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL1638881 0.71 LMNA (0.53) LMNAALDH1A1USP2THRBCYP1A2
SCHEMBL30754 0.71 LMNA (0.53) LMNAALDH1A1USP2THRBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160106091-A1 FREEZE PRESERVATION OF LIVING CELLS UNIVERSITE DE NAMUR (BE) 2016-04-21 US claimed
EP-3007554-A1 FREEZE PRESERVATION OF LIVING CELLS Université de Namur (BE) 2016-04-20 EP claimed
US-20150099289-A1 CARBONIC ANHYDRASE XEROGEL PARTICLES CO2 SOLUTIONS INC. (CA) 2015-04-09 US claimed
US-20150050712-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS CO2 SOLUTIONS INC. (CA) 2015-02-19 US claimed
EP-2834355-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS Akermin, Inc. (US) 2015-02-11 EP claimed
WO-2014198760-A1 FREEZE PRESERVATION OF LIVING CELLS UNIVERSITE DE NAMUR (BE) 2014-12-18 WO claimed
US-8895280-B2 Polysilicate-polysilicone enzyme immobilization materials AKERMIN, INC. (US) 2014-11-25 US claimed
US-20130267004-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS AKERMIN, INC. (US) 2013-10-10 US claimed
WO-2013151757-A1 POLYSILICATE-POLYSILICONE ENZYME IMMOBILIZATION MATERIALS AKERMIN, INC. (US) 2013-10-10 WO claimed
EP-1509533-B1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA UNIV MCMASTER (CA) 2009-10-21 EP claimed
WO-2008061363-A1 BIOMOLECULE COMPATIBLE SILICA PARTICLES MCMASTER UNIVERSITY (CA) 2008-05-29 WO claimed
US-20070207484-A1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA MCMASTER UNIVERSITY (CA) 2007-09-06 US claimed
EP-1509533-A1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA McMASTER UNIVERSITY (CA) 2005-03-02 EP claimed
US-20040034203-A1 Polyol-modified silanes as precursors for silica MCMASTER UNIVERSITY (CA) 2004-02-19 US claimed
WO-2003102001-A1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA MCMASTER UNIVERSITY (CA) 2003-12-11 WO claimed
EP-3204146-B1 PROCESSES FOR CARBON DIOXIDE CAPTURE WITH BIOCATALYST RECOVERY SYSTEM SAIPEM SPA (IT) 2022-12-07 EP disclosed
EP-3204146-A1 PROCESSES FOR CARBON DIOXIDE CAPTURE WITH BIOCATALYST RECOVERY SYSTEM CO2 Solutions Inc. (CA) 2017-08-16 EP disclosed
EP-1509533-A1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA McMASTER UNIVERSITY (CA) 2005-03-02 EP disclosed
US-20040034203-A1 Polyol-modified silanes as precursors for silica MCMASTER UNIVERSITY (CA) 2004-02-19 US disclosed
WO-2003102001-A1 POLYOL-MODIFIED SILANES AS PRECURSORS FOR SILICA MCMASTER UNIVERSITY (CA) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034203-A1 Polyol-modified silanes as precursors for silica SUGT1, SORD, UGCG LMNA 1981/4885ALDH1A1 2717/4885USP2 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.